Current Trend in Immunotherapy for Peanut Allergy

Area of Science:

• Immunology
• Allergology
• Microbiology

Background:

• Peanut allergy is a prevalent, lifelong hypersensitivity reaction with increasing global incidence.
• Current management relies on strict avoidance and epinephrine, lacking effective long-term treatments.
• Peanut allergy involves a T-helper type 2 (T_H2) immune response, characterized by specific IgE production.

Purpose of the Study:

• To review current immunotherapy strategies for peanut allergy.
• To explore the potential of probiotics in peanut allergy management.
• To discuss novel approaches modulating immune responses.

Main Methods:

• Review of existing literature on peanut allergy immunotherapy.
• Analysis of studies investigating oral immunotherapy (OIT), sublingual immunotherapy, and epicutaneous immunotherapy.
• Examination of research on lactic acid bacteria probiotics and their immunomodulatory effects in allergy.

Main Results:

• Established immunotherapy routes like OIT can induce desensitization and shift immune responses away from T_H2.
• Probiotics, including wild-type and recombinant strains with peanut allergens, show potential in down-regulating IgE and T_H2 responses.
• Probiotic interventions may increase beneficial T_H1 regulatory T cells (T_reg).

Conclusions:

• Immunotherapy offers a pathway to manage peanut allergy by rebalancing the immune system.
• Probiotic-based strategies represent a promising novel approach for peanut allergy treatment.
• Further research into probiotic immunotherapy could lead to effective disease management.